TLDR:
- German specialty chemicals company Evonik has invested in Chinese biotech company JLand Biotech, focusing on vegan collagen production.
- The partnership aims to develop collagen protein products for cosmetic and personal care applications to meet sustainability and consumer demand for bioactive ingredients.
Evolik, a German chemical company, has announced its investment in Chinese biotech firm, JLand Biotech, specializing in the production of vegan collagen. The exact amount of investment in JLand Biotech’s series round-B financing remains undisclosed. In addition to the investment, the two companies have signed a business cooperation agreement to focus on the development and restructuring of new collagen protein products. This partnership aims to enable Evonik to market large quantities of collagen for various applications, including anti-aging creams, masks, gels, hair masks, and conditioners, enhancing their presence in the cosmetic and personal care industry.
The use of vegan collagen, produced through a controlled fermentation-based process, offers advantages over animal-derived collagen in terms of formulation, skin absorption, and reproducibility. This aligns well with the global trend towards sustainability and the increasing consumer demand for effective bioactive ingredients in cosmetic products. As the demand for sustainable and effective bioactives continues to rise, Evonik believes that vegan collagen will become a key ingredient in cosmetic and personal care products.
Erning Cao, the investment director of Evonik Venture Capital, emphasized that this investment underscores the company’s commitment to sustainability and innovation while strengthening their business activities in cosmetic and personal care applications. The partnership with JLand Biotech is expected to enhance Evonik’s innovation ecosystem in China and contribute to the growth of the bioactive ingredients market in the region.
